# Belatacept Pharmacokinetic Trial in Renal Transplantation

> **NCT00578448** · PHASE2 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 14 (actual)

## Conditions studied

- Renal Transplantation

## Interventions

- **DRUG:** Belatacept

## Key facts

- **NCT ID:** NCT00578448
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2009-03
- **Final completion:** 2012-09
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2014-01-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00578448

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00578448, "Belatacept Pharmacokinetic Trial in Renal Transplantation". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00578448. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*